The Valley Desk

NCT03997123 · Interventional trial

Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC

Overall registry status Active not recruiting

Phase 3

Conditions Triple Negative Breast Neoplasms

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov